Logo image
Sign in
Rosuvastatin: A new HMG-CoA reductase inhibitor for the treatment of dyslipidemia
Journal article   Peer reviewed

Rosuvastatin: A new HMG-CoA reductase inhibitor for the treatment of dyslipidemia

Thomas L. Lenz, Michele A. Faulkner and Ann M. Ryan-Haddad
Advances in Pharmacy, Vol.2, pp.136-145
Spring 2004

Metrics

7 Record Views

Details